Syndicate This week's upcoming IPO's and secondary offerings

Week of October 21 to October 25, 2024

This Week's Deals to be Priced

10/24 - Thursday

Symbol

Issuer

Type

Price

Managers

AIH

Aesthetic Medical
Aesthetic Medical
IPO
$12.00
2.5M
Cantor Fitzgerald,...

Pricing after close
Deal analysis and details

Managers: Cantor Fitzgerald, Haitong & Prime Number Capital, MXIM, ZInvest, Tiger, Valuable Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

10/21 - Monday

Symbol

Issuer

Type

Price

Managers

SITC

Site Centers
Site Centers
Spot Secondary
Priced: $14.90
11.5M
Goldman Sachs & Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Goldman Sachs & Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/22 - Tuesday

Symbol

Issuer

Type

Price

Managers

NMFC

New Mountain Finance
New Mountain Finance
Spot Secondary
Priced: $13.25
8M
Wells Fargo,...

Pricing after close
Deal analysis and details

Managers: Wells Fargo, Morgan Stanley, BofA, Goldman Sachs, Keefe Bruyette, UBS & Deutsche Bank, Janney Montgomery Scott, Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
REED

Reed's
Reed's
Spot Secondary
Priced: $.60
11.667M
Roth MKM

Pricing after close

Managers: Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SLNO

Soleno Therapeutics
Soleno Therapeutics
Spot Secondary
Priced: $1.20
11.167M
Oppenheimer

Pricing after close
Deal analysis and details

Managers: Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/23 - Wednesday

Symbol

Issuer

Type

Price

Managers

BRP

BRP Group
BRP Group
IPO
Priced: $14.00
16.4M
JPMorgan & BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan & BofA, Jefferies, Wells Fargo, Raymond James, Keefe Bruyette

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/24 - Thursday

Symbol

Issuer

Type

Price

Managers

CABA

Cabaletta Bio
Cabaletta Bio
IPO
Priced: $11.00
8.8M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley, TD Cowen & Evercore ISI

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
DAO

Youdao
Youdao
IPO
Priced: $17.00
5.6M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, Morgan Stanley & Credit Suisse, CICC, HSBC

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
HAPP

Happiness Biotech
Happiness Biotech
IPO
Priced: $5.50
2M
Univest,...

Pricing after close

Managers: Univest, Aegis, Westpark, Newbridge

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PGNY

Progyny
Progyny
IPO
Priced: $13.00
10M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, Goldman Sachs & BofA, Citi

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
PHAT

Phathom Pharmaceuticals
Phathom Pharmaceuticals
IPO
Priced: $19.00
9.56M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Jefferies & Evercore ISI, Needham

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ARCE

Arco Platform
Arco Platform
Secondary
Priced: $43.00
7.72M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, Morgan Stanley & Itau BBA

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BIOL

Biolase
Biolase
Secondary
Priced: $.575
7.82M
Benchmark & DOTC

Pricing after close
Deal analysis and details

Managers: Benchmark & DOTC

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
TXMD

TherapeuticsMD
TherapeuticsMD
Secondary
Priced: $2.75
26M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, Stifel

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BYSI

BeyondSpring
BeyondSpring
Spot Secondary
Priced: $13.50
1.85M
Jefferies & William Blair

Pricing after close
Deal analysis and details

Managers: Jefferies & William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
OPK

Opko Health
Opko Health
Spot Secondary
Priced: $1.50
50M
Jefferies,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Jefferies, Piper Sandler & Guggenheim

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access